28
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Clinical and Laboratory Outcomes during the Treatment of Rheumatoid Arthritis with Methotrexate

, , , &
Pages 285-294 | Received 30 Jun 1989, Published online: 12 Jul 2009

References

  • Williams H J, Willkens R F, Samuelson CO, Jr, Alarcón G S, Guttadauria M, Yorboro C, Polisson R P, Weiner S R, Luggen M E, Billingsley L M, Dahl S L, Egger M J, Reading J C, Ward JR. Comparison of low-dow oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1985; 28: 721–30
  • Weinblatt M E, Trentham D E, Fraser P A, Holdsworth D E, Falchuk K R, Weissman B N, Coblyn JS. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988; 31: 167–75
  • Andersen P A, West S G, O'Dell J R, Via C S, Claypool R G, Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Ann Int Med 1985; 103: 489–96
  • Thompson R N, Watts C, Edelman J, Esdaile J, Russell AS. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheum 1984; 11: 760–3
  • Weinstein A, Marlowe S, Korn J, Farouhar F. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations. Am J Med 1985; 79: 331–7
  • Kremer J M, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986; 29: 822–31
  • Boerboom A M, Jeurissen M E, Westgeest A A, Theunisse H, Van de Putte LB. Methotrexate in refractory rheumatoid arthritis. Clin Rheumatol 1988; 7: 249–56
  • Dixon J S, Bird H A, Pickup M E, Wright V. Human model screening system for the detection of specific antirheumatic activity. Sem Arthritis Rheum 1982; 2: 185–90
  • Dixon JS. Biochemical and clinical changes in rheumatoid arthritis: Their relation to the action of antirheumatoid drugs. Sem Arthritis Rheum 1982; 2: 191–207
  • Dixon J S, Bird H A, Sitton N G, Pickup M E, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 1984; 13: 39–44
  • Ropes N W, Bennett G A, Cobb S, Jacox R, Jessar RA. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 1958, 175–6
  • Cannon G W, Egger M J, Ward J R, Blonquist L J, Collette LB. Quantitative solid phase fluorescence immunoassay of rheumatoid factor and C-reactive protein in active rheumatoid arthritis. Am J Clinical Path 1987; 87: 223–9
  • Burdash N M, Ponzio A D, Loadholt CB. A quantitative immunofl-orescence assay for IgM rheumatoid factor. J Rheumatol 1981; 8: 837–40
  • Robbins D L, Feigal DW, Jr, Leek JC. Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis. J Rheumatol 1986; 13: 259–62
  • Tishler M, Cawspi D, Yaron M. C-reactive protein levels in patients with rheumatoid arthritis: The impact of therapy. Clin Rheum 1985; 4: 321–4
  • Walsh L, Davies P, McConkey B. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 362–3
  • Morris M W, Pinals R S, Nelson DA. The zeta sedimentation ratio (ZSR) and activity of disease in rheumatoid arthritis. A.J.C.P., 6: 77, 760–2
  • Bucher W C, Gall E P, Woodworth R. Zeta sedimentation ratio in rheumatic disease. A.J.C.P., 64: 75, 613–7
  • Decker B, McGuckin W F, McKenzie B F, Slocumb CH. A study of some “acute phase reactants” in rheumatic diseases. Arthritis Rheum 1960; 3: 49–53
  • Mallya R K, de Beer F C, Berry H, Hamilton E DB, Mace B EW, Pepys MB. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982; 9: 224–8
  • Grindulis K A, Calvaley M, Constable T J, Forster P JG, Ahmed M EK, McConkey B. A comparison between clinical and laboratory tests in rheumatoid arthritis. Scand J Rheumatol 1983; 12: 285–8
  • Amos R S, Constable T J, Crockson R A, Crockson A P, McConkey B. Rheumatoid arthritis: Relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1977; 1: 195–7
  • Lessard J, Nunery E, Cecere F, McDuffy S, Pope RM. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors. J Rheumatol 1983; 10: 411–7
  • Pope R M, Lessard J, Nunnery E. Differential effects of therapeutic regimens on specific classes of rheumatoid factor. Ann Rheum Dis 1986; 46: 183–9
  • McConkey B, Crockson R A, Crockson A P, Wilkinson AR. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Quart J Med 1973; 168: 785–91
  • McGuire R J, Wright V. Statistical approach to indices of disease activity in rheumatoid arthritis. Ann Rheum Dis 1971; 30: 574–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.